Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Oxford researcher Dr Chunxiao Song has been awarded a CRUK-OHSU Project Award to work with Dr Thuy Ngo on liquid biopsy cancer diagnostic assays.

Cancer Research UK logoChunxiao Song, a group leader at the Ludwig Institute for Cancer Research, is developing a new highly sensitive technique to measure DNA methylation. This project award, jointly funded by CRUK and Oregon Health and Science University (OHSU) will allow him to collaborate with OHSU researcher Thuy Ngo. Thuy’s research focuses on the detection of RNA in the blood. Their aim is to use a combination of these epigenetic and transcriptome detection technologies to diagnose cancer earlier and provide information on where the cancer originated from. They will test their approach in the context of pancreatic and oesophageal cancer as these cancers have particularly low survival rates.

Read more about this story in the interview Chunxiao gave to CRUK here.

Update (February 2019): Chunxiao’s technology has been published in Nature Biotechnology. Read more about this here.

Similar stories

OxCODE researchers at the Early Detection of Cancer Conference 2022

Oxford’s early detection research was featured at this annual event.

Oxford Centre for Early Cancer Detection Symposium 2022 – a recap

On Tuesday 13th September, the Oxford early cancer detection community gathered at Worcester College to discuss the latest developments in this field, sparking ideas and collaborations for future research.